Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update

Over the past decade, immune checkpoint inhibitors (ICI) have revolutionized the treatment of advanced melanoma and ensured significant improvement in overall survival versus chemotherapy. ICI or targeted therapy are now the first line treatment in advanced melanoma, depending on the tumor v-raf mur...

Descripción completa

Detalles Bibliográficos
Autores principales: Vukadin, Sonja, Khaznadar, Farah, Kizivat, Tomislav, Vcev, Aleksandar, Smolic, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301472/
https://www.ncbi.nlm.nih.gov/pubmed/34356899
http://dx.doi.org/10.3390/biomedicines9070835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301472/
https://www.ncbi.nlm.nih.gov/pubmed/34356899
http://dx.doi.org/10.3390/biomedicines9070835

Ejemplares similares